FALCON_2 | R Documentation |
Kaplan-Meier digitized data from FALCON, figure 2 (PMID 27908454). A reported sample size of 462 for a primary endpoint of PFS in breast cancer.
FALCON_2
A data frame of 462 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (anastrazole, fulvestrant) | |
Robertson JFR, Bondarenko IM, Trishkina E, et al. Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. Lancet 2016; 388: 2997–3005.
summary(FALCON_2)
kmplot(FALCON_2)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.